4//SEC Filing
Schneiderman Daniel H 4
Accession 0001415889-20-000092
CIK 0001604191other
Filed
Jan 8, 7:00 PM ET
Accepted
Jan 9, 4:10 PM ET
Size
5.5 KB
Accession
0001415889-20-000092
Insider Transaction Report
Form 4
Schneiderman Daniel H
CHIEF FINANCIAL OFFICER
Transactions
- Award
Options
2020-01-02+335,006→ 335,006 totalExercise: $1.03Exp: 2030-01-02→ Common Stock (335,006 underlying)
Footnotes (1)
- [F1]Options granted in connection with the Reporting Person's appointment as Chief Financial Officer of the Issuer. The options will vest in three equal annual installments commencing on the first anniversary of the grant date, becoming fully vested on January 2, 2023.
Documents
Issuer
AzurRx BioPharma, Inc.
CIK 0001604191
Entity typeother
Related Parties
1- filerCIK 0001565536
Filing Metadata
- Form type
- 4
- Filed
- Jan 8, 7:00 PM ET
- Accepted
- Jan 9, 4:10 PM ET
- Size
- 5.5 KB